Status: Recruiting
Efficacy and Safety of CapsuleX Combined With Cisplatin in Platinum-Resistant Recurrent Ovarian Cancer: A Single-Arm Prospective Clinical Study
This trial was designed as a single-arm, open-label, prospective clinical trial to evaluate the efficacy (ORR) and safety (AE incidence) of CapsuleX in combination with cisplatin for platinum-resistant recurrent ovarian cancer (PROC).
Participants needed: 40
Trial details
Age: 18+Biological sex: FemaleType: InterventionalSponsor: The First Hospital of Jilin UniversityUpdated: Mar 27, 2026Locations: 1
Eligibility criteria
The subject can understand the informed consent, voluntarily participate and sig... [+11]
Primary platinum-refractory is defined as disease that has not been relieved (CR... [+22]